Pediatric pulmonology · 2025
Illness Burden in Adults With Cystic Fibrosis: Associations With Sex, Race/Ethnicity, and Socioeconomic Risk Factors.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
DiFiglia Stephanie, Georgiopoulos Anna M, Seng Elizabeth K, Portenoy Russell, Chaudhary Nivedita, Yonker Lael M, Wang Janice, Walker Patricia, Stables-Carney Teresa, Middour-Oxler Brandi, Linnemann Rachel W, Kier Catherine, Friedman Deborah, Berdella Maria N, Dhingra Lara
Аннотация
BACKGROUND: Illness burden in cystic fibrosis (CF) is variable and sociodemographic characteristics-including female sex, minoritized race/ethnicity, and lower socioeconomic status (SES)-may increase the risk of burden. More information about these associations is needed.
METHODS: This secondary analysis used baseline data from adults with CF (AwCF) participating in a palliative care implementation trial who completed questionnaires, including the Integrated Palliative Care Outcome Scale, Memorial Symptom Assessment Scale-Cystic Fibrosis, and Cystic Fibrosis Questionnaire-Revised. Bivariate analyses and general linear models evaluated associations between measures and potential vulnerabilities.
RESULTS: There were 273 AwCF (mean [SD] age: 38.7 [14.5] years; female: 59.3%; minoritized race/ethnicity: 10.6%; taking CFTR modulators: 84.2%; advanced illness: 20.9%). In bivariate analyses, females had more palliative care needs, higher symptom burden, and lower quality of life (QOL) than males. AwCF with minoritized race/ethnicity had less modulator use, more hospitalizations, and poorer QOL. Socioeconomic risk factors (SRFs; measured by a composite with 3 SES-related variables) were associated with more advanced disease, more palliative care needs, poorer QOL, and anxiety. In multivariate models adjusting for modulator treatment and advanced illness, female sex was associated with higher palliative care needs, higher symptom burden, and lower respiratory QOL; having ≥ 2 SRFs was associated with higher needs and lower QOL; and minoritized race/ethnicity was not associated with any of these measures.
CONCLUSIONS: Female sex and SRFs are independently associated with adults' CF illness burden. Burden associated with race/ethnicity may be mediated by other variables. These vulnerabilities should be investigated further and inform care.
METHODS: This secondary analysis used baseline data from adults with CF (AwCF) participating in a palliative care implementation trial who completed questionnaires, including the Integrated Palliative Care Outcome Scale, Memorial Symptom Assessment Scale-Cystic Fibrosis, and Cystic Fibrosis Questionnaire-Revised. Bivariate analyses and general linear models evaluated associations between measures and potential vulnerabilities.
RESULTS: There were 273 AwCF (mean [SD] age: 38.7 [14.5] years; female: 59.3%; minoritized race/ethnicity: 10.6%; taking CFTR modulators: 84.2%; advanced illness: 20.9%). In bivariate analyses, females had more palliative care needs, higher symptom burden, and lower quality of life (QOL) than males. AwCF with minoritized race/ethnicity had less modulator use, more hospitalizations, and poorer QOL. Socioeconomic risk factors (SRFs; measured by a composite with 3 SES-related variables) were associated with more advanced disease, more palliative care needs, poorer QOL, and anxiety. In multivariate models adjusting for modulator treatment and advanced illness, female sex was associated with higher palliative care needs, higher symptom burden, and lower respiratory QOL; having ≥ 2 SRFs was associated with higher needs and lower QOL; and minoritized race/ethnicity was not associated with any of these measures.
CONCLUSIONS: Female sex and SRFs are independently associated with adults' CF illness burden. Burden associated with race/ethnicity may be mediated by other variables. These vulnerabilities should be investigated further and inform care.